Heron Therapeutics's total assets for Q2 2025 were $232.09M, a decrease of -1.55% from the previous quarter. HRTX total liabilities were $259.35M for the fiscal quarter, a -1.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.